Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies
This review illustrates the salutary effects of neonatal Fc receptor (FcRn) overexpression in significantly improving humoral immune responses in the generation of antibodies for immunotherapy and diagnostics. These include: (1) improved IgG protection; (2) augmented antigen-specific humoral immune...
Gespeichert in:
| Veröffentlicht in: | mAbs 2011-09, Vol.3 (5), p.431-439 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 439 |
|---|---|
| container_issue | 5 |
| container_start_page | 431 |
| container_title | mAbs |
| container_volume | 3 |
| creator | Kacskovics, Imre Cervenak, Judit Erdei, Anna Goldsby, Richard A. Butler, John E. |
| description | This review illustrates the salutary effects of neonatal Fc receptor (FcRn) overexpression in significantly improving humoral immune responses in the generation of antibodies for immunotherapy and diagnostics. These include: (1) improved IgG protection; (2) augmented antigen-specific humoral immune response with larger numbers of antigen specific B cells, thus offering a wider spectrum of clones; (3) generation of antibodies against weakly immunogenic antigens; (4) significant improvements in the number and substantial developments in the diversity of hybridomas. FcRn transgenesis thus confers a number of practical benefits, including faster antibody production, higher antibody yields and improved generation of hybridomas for monoclonal antibody production. Notably, these efficiencies in polyclonal antibody production were also demonstrated in FcRn transgenic rabbits. Overall, FcRn transgenic animals yield more antibodies and provide a route to the generation of antibodies against antigens of low immunogenicity that are difficult to obtain using currently available methods. |
| doi_str_mv | 10.4161/mabs.3.5.17023 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3225847</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>903658339</sourcerecordid><originalsourceid>FETCH-LOGICAL-c528t-8fdf2936032704e7503c9eb7cfba2732adec2455cab32b4424291e9543e6075b3</originalsourceid><addsrcrecordid>eNqFkktv1DAUhSMEolXpliXyjtUEx488NkilagG1CKnA2nLs6xlDYgfbMzB_iV-Jk2lHsEB4E0s53zn35qQonle4ZFVdvRplH0ta8rJqMKGPitOqY2SF2wY_Pt5rclKcx_gVz6fBWfm0OCEEs7buyGnx6w4UuISk3kmnIKJttG6NrtWdQ34HAX5OAWK03iHrUArSxTU4q5B0dpRDRMkvOuVHQHacQNsx-0XkDYpJOi2Dztpke6_3KIHaOD_4tYWFzEDINEobQNkWgkxz0sxOoKxZchY2A8-KJyYnwvn986z4cn31-fLd6vbj2_eXF7crxUmbVq3RhnS0xpQ0mEHDMVUd9I0yvSQNJVKDIoxzJXtKesYII10FHWcUatzwnp4Vrw--07YfQc-fJ8hBTCEvHPbCSyv-fuPsRqz9TlBCeMuabPDy3iD471uISYw2KhgG6cBvo-gwrXlLaZeV5UGpgo8xgDmmVFjMFYu5YkEFF0vFGXjx52xH-UOhWcAPghymIfbWR2UhN3uU3kgVv_mdVfHDxZtPs_WkTebIf7hlEhmSVQMcp-kOkHXGh1H-8GHQIsn94IPJv4qyefZ_bPIb5Anitw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>903658339</pqid></control><display><type>article</type><title>Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Kacskovics, Imre ; Cervenak, Judit ; Erdei, Anna ; Goldsby, Richard A. ; Butler, John E.</creator><creatorcontrib>Kacskovics, Imre ; Cervenak, Judit ; Erdei, Anna ; Goldsby, Richard A. ; Butler, John E.</creatorcontrib><description>This review illustrates the salutary effects of neonatal Fc receptor (FcRn) overexpression in significantly improving humoral immune responses in the generation of antibodies for immunotherapy and diagnostics. These include: (1) improved IgG protection; (2) augmented antigen-specific humoral immune response with larger numbers of antigen specific B cells, thus offering a wider spectrum of clones; (3) generation of antibodies against weakly immunogenic antigens; (4) significant improvements in the number and substantial developments in the diversity of hybridomas. FcRn transgenesis thus confers a number of practical benefits, including faster antibody production, higher antibody yields and improved generation of hybridomas for monoclonal antibody production. Notably, these efficiencies in polyclonal antibody production were also demonstrated in FcRn transgenic rabbits. Overall, FcRn transgenic animals yield more antibodies and provide a route to the generation of antibodies against antigens of low immunogenicity that are difficult to obtain using currently available methods.</description><identifier>ISSN: 1942-0862</identifier><identifier>EISSN: 1942-0870</identifier><identifier>DOI: 10.4161/mabs.3.5.17023</identifier><identifier>PMID: 22048692</identifier><language>eng</language><publisher>United States: Taylor & Francis</publisher><subject>Animals ; Animals, Genetically Modified ; Antibodies, Monoclonal - biosynthesis ; Antibodies, Monoclonal - immunology ; Binding ; Biology ; Bioscience ; Biotechnology - methods ; Calcium ; Cancer ; Cell ; Cycle ; Guinea Pigs ; Histocompatibility Antigens Class I - genetics ; Histocompatibility Antigens Class I - metabolism ; Humans ; Immunoglobulin G - biosynthesis ; Immunoglobulin G - immunology ; Landes ; Mice ; Organogenesis ; Proteins ; Rabbits ; Receptors, Fc - genetics ; Receptors, Fc - metabolism ; Review ; Transgenes - genetics ; Transgenes - physiology ; Up-Regulation</subject><ispartof>mAbs, 2011-09, Vol.3 (5), p.431-439</ispartof><rights>Copyright © 2011 Landes Bioscience 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c528t-8fdf2936032704e7503c9eb7cfba2732adec2455cab32b4424291e9543e6075b3</citedby><cites>FETCH-LOGICAL-c528t-8fdf2936032704e7503c9eb7cfba2732adec2455cab32b4424291e9543e6075b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225847/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225847/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27923,27924,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22048692$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kacskovics, Imre</creatorcontrib><creatorcontrib>Cervenak, Judit</creatorcontrib><creatorcontrib>Erdei, Anna</creatorcontrib><creatorcontrib>Goldsby, Richard A.</creatorcontrib><creatorcontrib>Butler, John E.</creatorcontrib><title>Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies</title><title>mAbs</title><addtitle>MAbs</addtitle><description>This review illustrates the salutary effects of neonatal Fc receptor (FcRn) overexpression in significantly improving humoral immune responses in the generation of antibodies for immunotherapy and diagnostics. These include: (1) improved IgG protection; (2) augmented antigen-specific humoral immune response with larger numbers of antigen specific B cells, thus offering a wider spectrum of clones; (3) generation of antibodies against weakly immunogenic antigens; (4) significant improvements in the number and substantial developments in the diversity of hybridomas. FcRn transgenesis thus confers a number of practical benefits, including faster antibody production, higher antibody yields and improved generation of hybridomas for monoclonal antibody production. Notably, these efficiencies in polyclonal antibody production were also demonstrated in FcRn transgenic rabbits. Overall, FcRn transgenic animals yield more antibodies and provide a route to the generation of antibodies against antigens of low immunogenicity that are difficult to obtain using currently available methods.</description><subject>Animals</subject><subject>Animals, Genetically Modified</subject><subject>Antibodies, Monoclonal - biosynthesis</subject><subject>Antibodies, Monoclonal - immunology</subject><subject>Binding</subject><subject>Biology</subject><subject>Bioscience</subject><subject>Biotechnology - methods</subject><subject>Calcium</subject><subject>Cancer</subject><subject>Cell</subject><subject>Cycle</subject><subject>Guinea Pigs</subject><subject>Histocompatibility Antigens Class I - genetics</subject><subject>Histocompatibility Antigens Class I - metabolism</subject><subject>Humans</subject><subject>Immunoglobulin G - biosynthesis</subject><subject>Immunoglobulin G - immunology</subject><subject>Landes</subject><subject>Mice</subject><subject>Organogenesis</subject><subject>Proteins</subject><subject>Rabbits</subject><subject>Receptors, Fc - genetics</subject><subject>Receptors, Fc - metabolism</subject><subject>Review</subject><subject>Transgenes - genetics</subject><subject>Transgenes - physiology</subject><subject>Up-Regulation</subject><issn>1942-0862</issn><issn>1942-0870</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>0YH</sourceid><sourceid>EIF</sourceid><recordid>eNqFkktv1DAUhSMEolXpliXyjtUEx488NkilagG1CKnA2nLs6xlDYgfbMzB_iV-Jk2lHsEB4E0s53zn35qQonle4ZFVdvRplH0ta8rJqMKGPitOqY2SF2wY_Pt5rclKcx_gVz6fBWfm0OCEEs7buyGnx6w4UuISk3kmnIKJttG6NrtWdQ34HAX5OAWK03iHrUArSxTU4q5B0dpRDRMkvOuVHQHacQNsx-0XkDYpJOi2Dztpke6_3KIHaOD_4tYWFzEDINEobQNkWgkxz0sxOoKxZchY2A8-KJyYnwvn986z4cn31-fLd6vbj2_eXF7crxUmbVq3RhnS0xpQ0mEHDMVUd9I0yvSQNJVKDIoxzJXtKesYII10FHWcUatzwnp4Vrw--07YfQc-fJ8hBTCEvHPbCSyv-fuPsRqz9TlBCeMuabPDy3iD471uISYw2KhgG6cBvo-gwrXlLaZeV5UGpgo8xgDmmVFjMFYu5YkEFF0vFGXjx52xH-UOhWcAPghymIfbWR2UhN3uU3kgVv_mdVfHDxZtPs_WkTebIf7hlEhmSVQMcp-kOkHXGh1H-8GHQIsn94IPJv4qyefZ_bPIb5Anitw</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>Kacskovics, Imre</creator><creator>Cervenak, Judit</creator><creator>Erdei, Anna</creator><creator>Goldsby, Richard A.</creator><creator>Butler, John E.</creator><general>Taylor & Francis</general><general>Landes Bioscience</general><scope>0YH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20110901</creationdate><title>Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies</title><author>Kacskovics, Imre ; Cervenak, Judit ; Erdei, Anna ; Goldsby, Richard A. ; Butler, John E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c528t-8fdf2936032704e7503c9eb7cfba2732adec2455cab32b4424291e9543e6075b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Animals, Genetically Modified</topic><topic>Antibodies, Monoclonal - biosynthesis</topic><topic>Antibodies, Monoclonal - immunology</topic><topic>Binding</topic><topic>Biology</topic><topic>Bioscience</topic><topic>Biotechnology - methods</topic><topic>Calcium</topic><topic>Cancer</topic><topic>Cell</topic><topic>Cycle</topic><topic>Guinea Pigs</topic><topic>Histocompatibility Antigens Class I - genetics</topic><topic>Histocompatibility Antigens Class I - metabolism</topic><topic>Humans</topic><topic>Immunoglobulin G - biosynthesis</topic><topic>Immunoglobulin G - immunology</topic><topic>Landes</topic><topic>Mice</topic><topic>Organogenesis</topic><topic>Proteins</topic><topic>Rabbits</topic><topic>Receptors, Fc - genetics</topic><topic>Receptors, Fc - metabolism</topic><topic>Review</topic><topic>Transgenes - genetics</topic><topic>Transgenes - physiology</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kacskovics, Imre</creatorcontrib><creatorcontrib>Cervenak, Judit</creatorcontrib><creatorcontrib>Erdei, Anna</creatorcontrib><creatorcontrib>Goldsby, Richard A.</creatorcontrib><creatorcontrib>Butler, John E.</creatorcontrib><collection>Taylor & Francis Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>mAbs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kacskovics, Imre</au><au>Cervenak, Judit</au><au>Erdei, Anna</au><au>Goldsby, Richard A.</au><au>Butler, John E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies</atitle><jtitle>mAbs</jtitle><addtitle>MAbs</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>3</volume><issue>5</issue><spage>431</spage><epage>439</epage><pages>431-439</pages><issn>1942-0862</issn><eissn>1942-0870</eissn><abstract>This review illustrates the salutary effects of neonatal Fc receptor (FcRn) overexpression in significantly improving humoral immune responses in the generation of antibodies for immunotherapy and diagnostics. These include: (1) improved IgG protection; (2) augmented antigen-specific humoral immune response with larger numbers of antigen specific B cells, thus offering a wider spectrum of clones; (3) generation of antibodies against weakly immunogenic antigens; (4) significant improvements in the number and substantial developments in the diversity of hybridomas. FcRn transgenesis thus confers a number of practical benefits, including faster antibody production, higher antibody yields and improved generation of hybridomas for monoclonal antibody production. Notably, these efficiencies in polyclonal antibody production were also demonstrated in FcRn transgenic rabbits. Overall, FcRn transgenic animals yield more antibodies and provide a route to the generation of antibodies against antigens of low immunogenicity that are difficult to obtain using currently available methods.</abstract><cop>United States</cop><pub>Taylor & Francis</pub><pmid>22048692</pmid><doi>10.4161/mabs.3.5.17023</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1942-0862 |
| ispartof | mAbs, 2011-09, Vol.3 (5), p.431-439 |
| issn | 1942-0862 1942-0870 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3225847 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
| subjects | Animals Animals, Genetically Modified Antibodies, Monoclonal - biosynthesis Antibodies, Monoclonal - immunology Binding Biology Bioscience Biotechnology - methods Calcium Cancer Cell Cycle Guinea Pigs Histocompatibility Antigens Class I - genetics Histocompatibility Antigens Class I - metabolism Humans Immunoglobulin G - biosynthesis Immunoglobulin G - immunology Landes Mice Organogenesis Proteins Rabbits Receptors, Fc - genetics Receptors, Fc - metabolism Review Transgenes - genetics Transgenes - physiology Up-Regulation |
| title | Recent advances using FcRn overexpression in transgenic animals to overcome impediments of standard antibody technologies to improve the generation of specific antibodies |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T18%3A52%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recent%20advances%20using%20FcRn%20overexpression%20in%20transgenic%20animals%20to%20overcome%20impediments%20of%20standard%20antibody%20technologies%20to%20improve%20the%20generation%20of%20specific%20antibodies&rft.jtitle=mAbs&rft.au=Kacskovics,%20Imre&rft.date=2011-09-01&rft.volume=3&rft.issue=5&rft.spage=431&rft.epage=439&rft.pages=431-439&rft.issn=1942-0862&rft.eissn=1942-0870&rft_id=info:doi/10.4161/mabs.3.5.17023&rft_dat=%3Cproquest_pubme%3E903658339%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=903658339&rft_id=info:pmid/22048692&rfr_iscdi=true |